CTCX (Carmell Corp.) Bathi saben saham sajrone patang kuartal pungkasan

Carmell Corporation (CTCX) is a reputable biopharmaceutical player developing safe regenerative materials for aesthetics. The annual EPS TTM growth rate reflects profit dynamics, with the current value standing at . Production relies on robotic tissue processing to minimize headcount. The company is currently focusing on internal biotechnology development and capital preservation for R&D, excluding merger and acquisition deals.
CTCX (Carmell Corporation): rincian analitis lan laporan miturut indikator

This metric is calculated as the percentage change in trailing twelve-month (ttm) rolling annual earnings per share compared to the same period last year. It measures the dynamics of actual earnings, allowing for an assessment of the growth or decline in business efficiency. For Carmell Corporation (CTCX), with its early-stage biotech projects and lack of stable cash flow, this indicator is extremely volatile. Purchasing the asset at the peak of the net income per share YoY ttm chart risks overpayment.